Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,458 total articles
Meta (META) trades at roughly 20x earnings for a core advertising franchise that still generates strong cash flow. AI-driven product upgrades and advertiser targeting improvements are optional upside. We lay out an actionable long trade with entry, stop and target, a 180-trading-day horizon, and a balanced risk framework.
Argan (AGX) sold off aggressively into early November but the fundamentals - $1.03B cash, no debt, FCF of $545.7M and 61.5% revenue growth in the latest quarter - argue for a mid-term long. This trade targets a re-test of the $370 area while limiting downside with a $280 stop.
Adobe's fundamentals still look solid: $10.6B in free cash flow, a $92B market cap, and mid‑teens revenue growth guidance. The market is pricing AI‑risk into the stock; a cash‑secured put lets you collect premium today and either pocket income or be assigned shares at a lower effective cost. This trade outlines a mid‑term (45 trading days) put sale…
Intel's share price has reset sharply from the year's highs. The business still generates meaningful free cash flow, carries a modest leverage profile, and trades at valuation multiples that look reasonable relative to its market cap and AI exposure. This trade idea outlines a mid-term (45 trading days) long with strict risk controls and the scenar…
Oneok's ~$4.4B Brazos acquisition and an Apollo tie-up materially change its growth optionality while the stock still trades at a reasonable multiple. The combination of a 4.9% yield, $2.53B in free cash flow, and an EV/EBITDA near 11 supports a position trade. This piece lays out the trade plan, catalysts, valuation framing and risks.
Celestica (CLS) looks attractively priced after a sizeable multi-month selloff. The business sits squarely in AI networking and data-center manufacturing, and the stock trades at a reasonable multiple vs. its cash flow and growth signals. We outline a clear entry, stop and target for a mid-term swing trade and highlight catalysts and risks that cou…
Gen Digital (GEN) reported Q2 FY2027 results that beat estimates, raised full-year guidance to $5.465-$5.515B and $2.93-$2.98 EPS, and highlighted accelerating Trust-Based Solutions and high Cyber Safety margins. At the current price, the stock is trading near 10x FY27 midpoint EPS and below historical growth-comparable multiple on improving fundam…
Root has shifted from growth-at-all-costs to durable profitability. With positive free cash flow of $194.5M, an EV of $349M and an EV/EBITDA of 3.5, the stock is priced for a much worse outcome than fundamentals now imply. I rate ROOT a strong buy and lay out a concrete entry, stop and target for a long-term trade (180 trading days).
Nano Labs (NA) trades at a $30M market cap after a painful H1 2026 loss tied to BNB fair value swings. The company is pivoting to AI hardware and Web3 infrastructure; the shares are oversold and cheap on a price-to-book basis. This is a speculative long: asymmetric upside if product and RWA initiatives gain traction and crypto prices rebound, but m…
Bank of Nova Scotia combines a 3.5% yield, stable capital metrics and exposure to accelerating fee businesses. With a market cap of $114B, P/E ~16.8 and the stock sitting close to its 50-day moving average, we initiate a constructive trade ahead of Q4 results. Trade plan: enter $92.50, stop $88.00, target $99.00 - mid term (45 trading days).
Amdocs (DOX) has plunged roughly 30% after a legal dispute with T-Mobile and conservative 2027 guidance. The fall leaves the stock trading near $41.50 with a sub-9x P/E, EV/EBITDA ~5.6 and a yield north of 5%. For risk-tolerant traders willing to accept headline risk, this is a speculative value entry: buy on weakness, limit exposure, and watch leg…
We upgrade Apple to a Buy. At $348.80, valuation already bakes in slower near-term growth; Apple's $136B free cash flow, P/E ~39 and $5.07T market cap create a low-risk entry for a mid-term trade capturing AI feature rollouts and seasonal demand.
Lancaster Colony’s Marzetti-led business showed a disappointing Q1, but the drivers of that weakness look temporary and visible: seasonal volume softness, elevated trade and promotional activity, and lingering commodity pressure. With expectations muted, this trade captures a mid-term rebound that should materialize as volumes normalize and margins…
VersaBank ($VBNK) is a small, digital-first Canadian bank with a punchy set of growth levers: U.S. expansion via a Structured Receivable Purchase program, custody revenue from stablecoin custody, plus improving technical momentum. The stock has already re-rated from its 52-week low; with a market cap of ~$779M and price near $24, a mid-term swing t…
SK hynix combines cyclical deep-value characteristics with structural upside from memory pricing normalization and potential arbitrage between listings. This trade targets a recovery scenario while protecting capital with a clear stop.
Reddit plunged after Q3 results on concerns around Google search referrals and rising costs, but advertising growth (54% YoY), 12% DAU expansion, and near‑term conversion upside from logged‑in traffic create a high‑conviction buy setup. Entry $98.68, stop $82.00, target $150.00 over a 180‑day horizon.
Selective Insurance (SIGI) reported a materially better combined ratio in Q3 and saw investment income rise ~16%, driving an earnings beat. The stock trades at a mid-teens earnings multiple and looks reasonably valued versus cash flow, making a selective long trade attractive over the next 3-6 months - provided premium trends stabilize and catastro…
CRISPR Therapeutics (CRSP) has seen short interest drop from ~26.6M shares on 06/15/2026 to ~16.4M on 10/15/2026 - roughly a 40% decline. That pullback in bearish positioning, combined with Q3 revenue beats and encouraging zugo-cel data, creates a mid-term long opportunity. Trade plan below: entry $45.00, stop $40.00, target $55.00 for a 45 trading…
Coloplast B (CLPBF) has stabilised after a weak stretch and is showing constructive technicals: price above short- and medium-term moving averages, rising MACD and an RSI under pressure but not overbought. The fundamental picture is unclear from public U.S. OTC data, but the chart suggests a tactical, mid-term long with modest upside to $78 and a c…
OMS Energy (OMSE) is a low-multiple, profitable oilfield equipment supplier trading close to its tangible value. Recent $11M Aramco call-off, $2.6M SWS orders and API 6A/11D1 certifications improve revenue visibility. With a market cap of $163.9M and a P/E of ~5, the stock offers asymmetric upside if the company converts backlog and expands certifi…
AMC Global Media (AMCX) saw recent legal-related cash-flow pressure that pressured the stock despite an EPS beat. With free cash flow of $190.5M, an EV/EBITDA of 5.6x and a sub-$350M market cap, the risk/reward favors a disciplined swing trade. Entry $8.30, stop $7.00, target $12.00, horizon: mid term (45 trading days).
iShares Future AI & Tech ETF (ARTY) remains a core way to own the AI hardware-to-software rally. After a 51% lift since an earlier buy call, the ETF has pulled back into technical support and offers a controlled swing trade with defined risk-reward tied to continued AI capex and earnings beats across the ecosystem.
Alphabet’s introduction of advanced AI accelerators validates a massive, multi-hundred-billion-dollar AI silicon market. That’s good news for AMD: the company is already growing data-center revenue at triple-digit rates, guiding for very large top-line expansion, and sitting on healthy cash flow and low leverage. I’m proposing a swing trade to ride…
IperionX (IPX) is a small-cap developer of low-carbon titanium that looks attractively positioned for U.S. supply-chain reshoring. Recent asset consolidation, meaningful short interest and improving technical momentum create an asymmetric trade: enter near $15.50, stop at $13.00, target $25.00 over a position trade horizon (180 trading days). Risks…
Nvidia has been knocked lower by revelations about CEO Jen Hsun Huang and ensuing federal scrutiny. The fundamentals - massive free cash flow, high ROE, low leverage, and AI-driven data-center demand - remain intact. This trade idea proposes a long entry at the recent price, a protective stop to limit headline-driven downside, and a target that cap…
